Anticipated Spike in Deal Activity in 2021 Makes Customized R&W Insurance Critical, Finds Lowenstein Sandler

NEW YORK–(BUSINESS WIRE)–Encouraging news about COVID-19 vaccination trials and the impending resolution of the long election process bode well for deal activity in 2021, according to M&A and insurance recovery lawyers from Lowenstein Sandler. With an anticipated increase in financial transactions, competition among insurers is also expected to heat up, making this an ideal time … [Read more…]

ImmunityBio Simulates SARS-CoV-2 Spike Protein Binding Using Molecular Dynamics

Detailed computer modeling, completed in partnership with Microsoft, explains virulence of COVID-19 and provides key information that may lead to a better understanding of the multiple mutations currently occurring to the “spike” protein as the virus evolves Computer-based molecular dynamics simulation allows highly detailed visualization of free (unbound) spike receptor binding domain (S RBD) and … [Read more…]

Vicks® Donates $1 million for COVID-19 Health Care Relief

Humanitarian Aid Organization, Direct Relief, will use the funds to deliver protective gear and essential medical aid to health care organizations CINCINNATI–(BUSINESS WIRE)–In response to the novel coronavirus (COVID-19) pandemic, the Vicks® family of cold and flu brands – NyQuil™, DayQuil™ and VapoRub™ – will donate $1 million to Direct Relief, one of the world’s … [Read more…]

Worldwide qPCR Instruments Industry to 2028 – Technological Advancements in PCR are Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “qPCR Instruments Market Size, Share & Trends Analysis Report By Instrument (GeneXpert, BioFireFilmArray Systems, BMS Mic System), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering. The global qPCR instruments market size is expected to reach USD 1.39 billion by 2028, … [Read more…]

Global Proteomics Market Trajectory & Analytics Research Report 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Proteomics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Proteomics Market to Reach $43.5 Billion by 2026 The proteomics market is anticipated to gain from the pressing need to develop advanced therapeutic and diagnostic options in the wake of COVID-19. The ability of proteomics to help researchers … [Read more…]

Global Nitrile Gloves Market Trajectory & Analytics Report 2021-2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Nitrile Gloves – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Nitrile Gloves Market to Reach $57.1 Billion by 2026 Amid the COVID-19 crisis, the global market for Nitrile Gloves estimated at US$14.1 Billion in the year 2020, is projected to reach a revised size of US$57.1 Billion … [Read more…]

Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress

ARCT-021, Arcturus’ single shot STARR™ mRNA COVID vaccine, to begin multinational placebo-controlled Phase 3 efficacy study funded and sponsored by a global entity ARCT-154, Arcturus’ STARR™ mRNA vaccine candidate targeting COVID variants of concern, elicits robust neutralizing antibody titers against all variants tested in primates, including the Delta variant ARCT-154 to begin staged Phase 3 … [Read more…]

Global Biopharmaceutical Tubing Market to 2028 – COVID-19 Impact and Analysis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biopharmaceutical Tubing Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Type (Plastic, Metal, Silicone); Application (Pharmaceutical, Medical Devices, Research and Development, Others), and Geography.” report has been added to ResearchAndMarkets.com’s offering. According to this report the market is expected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million … [Read more…]

VBI Vaccines Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Hepatitis B (HBV) : FDA and EMA regulatory review of VBI’s 3-antigen prophylactic HBV vaccine candidate ongoing – U.S. PDUFA target action date November 30, 2021 COVID-19 : Expected Q3 2021 initiation of the next phase of development of VBI-2905 Beta variant, including both one-dose booster and two dose regimens, for seropositive and seronegative individuals, … [Read more…]

HUMIRA (Adalimumab) Biosimilars Report 2021: Focus on Approved & Launched, Investigational & Research Use, Inactive/Terminated/Withdrawn, Industry/Non-Industry Partnerships – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “HUMIRA® (Adalimumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships” report has been added to ResearchAndMarkets.com’s offering. The “Adalimumab Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships” report features an extensive study of the current developer landscape … [Read more…]